424
Views
21
CrossRef citations to date
0
Altmetric
Report

Distinctive effects of the cellular inhibitor of apoptosis protein c-IAP2 through stabilization by XIAP in glioblastoma multiforme cells

, , , &
Pages 992-1005 | Received 13 Sep 2013, Accepted 16 Jan 2014, Published online: 22 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Shokoofeh Ghaemi, Zahra Fekrirad, Nina Zamani, Rana Rahmani & Ehsan Arefian. (2022) Non-coding RNAs enhance the apoptosis efficacy of therapeutic agents used for the treatment of glioblastoma multiform. Journal of Drug Targeting 30:6, pages 589-602.
Read now
Omar S. Khan, Ajaz A. Bhat, Roopesh Krishnankutty, Ramzi M. Mohammad & Shahab Uddin. (2016) Therapeutic Potential of Resveratrol in Lymphoid Malignancies. Nutrition and Cancer 68:3, pages 365-373.
Read now

Articles from other publishers (19)

Yung-Chih Kuo, Yin-Jung Lee & Rajendiran Rajesh. (2022) Enhanced activity of AZD5582 and SM-164 in rabies virus glycoprotein-lactoferrin-liposomes to downregulate inhibitors of apoptosis proteins in glioblastoma. Biomaterials Advances 133, pages 112615.
Crossref
Dariimaa Ganbat, Bat-Erdene Jugder, Lkhamaa Ganbat, Miki Tomoeda, Erdenetsogt Dungubat, Ambaga Miyegombo, Gantsetseg Garmaa, Yoshihisa Takahashi, Ryuji Fukuzawa, Ichiro Mori, Takayuki Shiomi, Akinori Nakata & Yasuhiko Tomita. (2022) Use of the Naphthoquinone YM155 (Sepantronium Bromide) in the Treatment of Cancer: A Systematic Review and Meta-Synthesis. Oncologie 24:2, pages 195-225.
Crossref
Raffaele Frazzi. (2021) BIRC3 and BIRC5: multi‐faceted inhibitors in cancer. Cell & Bioscience 11:1.
Crossref
David Cerna, Bora Lim, Yusuf Adelabu, Stephen Yoo, Donna Carter, Ahmed Fahim, Yasuhiro Mitsuuchi, Beverly A. Teicher, Eric Bernhard, C. Norman Coleman, Naoko Takebe & Mansoor M. Ahmed. (2021) SMAC Mimetic/IAP Inhibitor Birinapant Enhances Radiosensitivity of Glioblastoma Multiforme. Radiation Research 195:6.
Crossref
Yang Cao, Hang Zhou, Xiaoyu Chen, Yin Li, Junwen Hu, Guoyang Zhou & Lin Wang. (2021) Recent insight into the role of RING-finger E3 ligases in glioma. Biochemical Society Transactions 49:1, pages 519-529.
Crossref
Chun Hei Antonio Cheung, Yung-Chieh Chang, Tzu-Yu Lin, Siao Muk Cheng & Euphemia Leung. (2020) Anti-apoptotic proteins in the autophagic world: an update on functions of XIAP, Survivin, and BRUCE. Journal of Biomedical Science 27:1.
Crossref
Nico Scholz, Kathreena M. Kurian, Florian A. Siebzehnrubl & Julien D. F. Licchesi. (2020) Targeting the Ubiquitin System in Glioblastoma. Frontiers in Oncology 10.
Crossref
Dana Mamriev, Ruqaia Abbas, Franca-Maria Klingler, Juliana Kagan, Nir Kfir, Alastair Donald, Keren Weidenfeld, David W. Sheppard, Dalit Barkan & Sarit Larisch. (2020) A small-molecule ARTS mimetic promotes apoptosis through degradation of both XIAP and Bcl-2. Cell Death & Disease 11:6.
Crossref
Aurélie Soubéran, Jessica Cappaï, Mathieu Chocry, Christopher Nuccio, Julie Raujol, Carole Colin, Daniel Lafitte, Hervé Kovacic, Véronique Quillien, Nathalie Baeza-Kallee, Geneviève Rougon, Dominique Figarella-Branger & Aurélie Tchoghandjian. (2019) Inhibitor of Apoptosis Proteins Determines Glioblastoma Stem-Like Cell Fate in an Oxygen-Dependent Manner. Stem Cells 37:6, pages 731-742.
Crossref
Cintia Carla da Hora, Kelsey Pinkham, Litia Carvalho, Max Zinter, Elie Tabet, Ichiro Nakano, Bakhos A. Tannous & Christian E. Badr. (2019) Sustained NF-κB-STAT3 signaling promotes resistance to Smac mimetics in Glioma stem-like cells but creates a vulnerability to EZH2 inhibition. Cell Death Discovery 5:1.
Crossref
Lisa J. Schlein, Bahaa Fadl-Alla, Holly C. Pondenis, Stéphane Lezmi, Charles G. Eberhart, Amy K. LeBlanc, Peter J. Dickinson, Paul J. Hergenrother & Timothy M. Fan. (2019) Immunohistochemical Characterization of Procaspase-3 Overexpression as a Druggable Target With PAC-1, a Procaspase-3 Activator, in Canine and Human Brain Cancers. Frontiers in Oncology 9.
Crossref
Sze Kiat Tan, Anna Jermakowicz, Adnan K. Mookhtiar, Charles B. Nemeroff, Stephan C. Schürer & Nagi G. Ayad. (2018) Drug Repositioning in Glioblastoma: A Pathway Perspective. Frontiers in Pharmacology 9.
Crossref
Loyola V. Gressot, Tiffany Doucette, Yuhui Yang, Gregory N. Fuller, Ganiraju Manyam, Arvind Rao, Khatri Latha & Ganesh Rao. (2016) Analysis of the inhibitors of apoptosis identifies BIRC3 as a facilitator of malignant progression in glioma. Oncotarget 8:8, pages 12695-12704.
Crossref
Silvia Anahi Valdés-Rives, Diana Casique-Aguirre, Liliana Germán-Castelán, Marco A. Velasco-Velázquez & Aliesha González-Arenas. (2017) Apoptotic Signaling Pathways in Glioblastoma and Therapeutic Implications. BioMed Research International 2017, pages 1-12.
Crossref
S. Zappavigna, M. Scuotto, A. M. Cossu, D. Ingrosso, M. De Rosa, C. Schiraldi, R. Filosa & M. Caraglia. (2016) The 1,4 benzoquinone-featured 5-lipoxygenase inhibitor RF-Id induces apoptotic death through downregulation of IAPs in human glioblastoma cells. Journal of Experimental & Clinical Cancer Research 35:1.
Crossref
Dapeng Wang, Anders Berglund, Rajappa S. Kenchappa, Peter A. Forsyth, James J. Mulé & Arnold B. Etame. (2016) BIRC3 is a novel driver of therapeutic resistance in Glioblastoma. Scientific Reports 6:1.
Crossref
I. Vitale, G. Manic, G. Kroemer & L. Galluzzi. 2016. Encyclopedia of Cell Biology. Encyclopedia of Cell Biology 341 353 .
Vivien Landré, Barak Rotblat, Sonia Melino, Francesca Bernassola & Gerry Melino. (2014) Screening for E3-Ubiquitin ligase inhibitors: challenges and opportunities. Oncotarget 5:18, pages 7988-8013.
Crossref
Zipeng Cao, Xueyong Li, Jingxia Li, Wenjing Luo, Chuanshu Huang & Jingyuan Chen. (2014) X-linked inhibitor of apoptosis protein (XIAP) lacking RING domain localizes to the nuclear and promotes cancer cell anchorage-independent growth by targeting the E2F1/Cyclin E axis. Oncotarget 5:16, pages 7126-7137.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.